171 related articles for article (PubMed ID: 20865790)
21. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
23. New insights in CD28-independent allograft rejection.
Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
[TBL] [Abstract][Full Text] [Related]
24. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
[TBL] [Abstract][Full Text] [Related]
25. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells.
Zecher D; Li Q; Oberbarnscheidt MH; Demetris AJ; Shlomchik WD; Rothstein DM; Lakkis FG
J Immunol; 2010 Jun; 184(12):6649-57. PubMed ID: 20483732
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.
Guo H; Wang W; Zhao N; He X; Zhu L; Jiang X
Transpl Immunol; 2013 Dec; 29(1-4):99-104. PubMed ID: 24103733
[TBL] [Abstract][Full Text] [Related]
27. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
28. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
El-Sawy T; Miura M; Fairchild R
Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
[TBL] [Abstract][Full Text] [Related]
29. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
30. Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help.
Jones ND; Carvalho-Gaspar M; Luo S; Brook MO; Martin L; Wood KJ
J Immunol; 2006 Feb; 176(4):2316-23. PubMed ID: 16455988
[TBL] [Abstract][Full Text] [Related]
31. Allograft rejection mediated by memory T cells is resistant to regulation.
Yang J; Brook MO; Carvalho-Gaspar M; Zhang J; Ramon HE; Sayegh MH; Wood KJ; Turka LA; Jones ND
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19954-9. PubMed ID: 18042727
[TBL] [Abstract][Full Text] [Related]
32. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner.
Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781
[TBL] [Abstract][Full Text] [Related]
33. Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection.
Wan N; Dai H; Wang T; Moore Y; Zheng XX; Dai Z
J Immunol; 2008 Jan; 180(1):113-21. PubMed ID: 18097010
[TBL] [Abstract][Full Text] [Related]
34. Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.
Azzi J; Ohori S; Ting C; Uehara M; Abdoli R; Smith BD; Safa K; Solhjou Z; Lukyanchykov P; Patel J; McGrath M; Abdi R
Am J Transplant; 2015 Jan; 15(1):234-41. PubMed ID: 25534448
[TBL] [Abstract][Full Text] [Related]
35. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
Diamond AS; Gill RG
J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
[TBL] [Abstract][Full Text] [Related]
36. Lymphopenia-induced homeostatic proliferation of CD8+ T cells is a mechanism for effective allogeneic skin graft rejection following burn injury.
Maile R; Barnes CM; Nielsen AI; Meyer AA; Frelinger JA; Cairns BA
J Immunol; 2006 Jun; 176(11):6717-26. PubMed ID: 16709831
[TBL] [Abstract][Full Text] [Related]
37. IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.
Iida S; Tsuda H; Tanaka T; Kish DD; Abe T; Su CA; Abe R; Tanabe K; Valujskikh A; Baldwin WM; Fairchild RL
J Immunol; 2016 Mar; 196(6):2827-37. PubMed ID: 26856697
[TBL] [Abstract][Full Text] [Related]
38. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice.
Minamimura K; Sato K; Yagita H; Tanaka T; Arii S; Maki T
Am J Transplant; 2008 Apr; 8(4):761-72. PubMed ID: 18261171
[TBL] [Abstract][Full Text] [Related]
39. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
40. Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells.
Oberbarnscheidt MH; Obhrai JS; Williams AL; Rothstein DM; Shlomchik WD; Chalasani G; Lakkis FG
Am J Transplant; 2010 Jan; 10(1):162-7. PubMed ID: 19951284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
